Invivyd Reports Positive Phase 3 LIBERTY Data for VYD2311
NEW HAVEN, Conn. — September 29, 202 Invivyd announced topline results from the Phase 3 LIBERTY study evaluating VYD2311,...
SARS-CoV-2
Advertisement
Sunshine Biopharma Advances PLpro Inhibitor Toward IND
FORT LAUDERDALE, Fla. — September 16, 2026 Sunshine Biopharma Inc. announced that it has advanced its lead Coronavirus drug...
Aptitude Metrix COVID Test Receives FDA 510(k) Clearance
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
Moderna Wins FDA Approval for 2026-27 COVID Vaccines
Cambridge, Massachusetts, August 27, 2026 Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved supplemental...
Pfizer and BioNTech Win FDA Approval for XFG COVID-19 Vaccine
NEW YORK, NY and MAINZ, Germany – August 27, 2026 Pfizer Inc. and BioNTech SE announced that the U.S....
Advertisements
Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine
NEW YORK and MAINZ, Germany, July 29, 2026 Pfizer Inc. and BioNTech SE announced that the European Commission (EC)...
Vaxart Reports Positive 12-Month Phase 2b Safety Data
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Vaxart, Inc. has announced positive topline 12-month safety results from the approximately...
Invivyd Receives FDA EUA Termination Notice for PEMGARDA
NEW HAVEN, Conn., July 6, 2026 Invivyd announced that the U.S. Food and Drug Administration (FDA) has issued a...
AdJane Validates OMV Vaccine Platform in Human Phase I Trial
DELFT, The Netherlands, June 30, 2026 AdJane, a clinical-stage vaccine platform company, has announced the publication of first-in-human Phase...
AMDI Wins FDA Approval for Sub-10-Minute Respiratory PCR Test
SANTA ANA, California, June 16, 2026 Autonomous Medical Devices Incorporated (AMDI) announced that the U.S. Food and Drug Administration...
Advertisement
